Proteomics has become an important field in molecular sciences, as it provides valuable
information on the identity, expression levels, and modification of proteins. For example …

Mass spectrometry (MS)-based proteomics have been increasingly implemented in various
disciplines of laboratory medicine to identify and quantify biomolecules in a variety of …

Glioblastoma (GBM) is the most common intrinsic and aggressive primary brain tumor in
adults, with a median survival of approximately 15 months. GBM heterogeneity is considered …

High-grade adult-type diffuse gliomas are malignant neuroepithelial tumors with poor
survival rates in combined chemoradiotherapy. The current WHO classification is based on …

Drug resistance is a major challenge in the treatment of advanced cholangiocarcinoma
(CCA). Understanding the mechanisms of drug resistance can aid in identifying novel …

Y-box binding protein 1 (YBX1), a member of the Cold Shock Domain protein family, is
overexpressed in various human cancers and is recognized as an oncogenic gene …

Accumulating studies have confirmed the crucial role of long non-coding RNAs (ncRNAs) as
favorable biomarkers for cancer diagnosis, therapy, and prognosis prediction. In our recent …

Glioblastoma (GBM) is the most common primary brain tumor with a median survival under
two years. Using in silico and in vitro techniques, we demonstrate heterogeneous …

In this study, we aimed to explore the potential differences in proteomic profiles from the
testicular tissue of azoospermatic men with impaired spermatogenesis and normal …

Adult-onset brain cancers, such as glioblastomas, are particularly lethal. People with
glioblastoma multiforme (GBM) do not anticipate living for more than 15 months if there is no …